Abstract
The Brown University AIDS Program and the Rhode Island Department of Health joined with health care practitioners, researchers, and representatives of community-based health, social service, and advocacy organizations to create comprehensive guidelines on nonoccupational HIV postexposure prophylaxis for the state of Rhode Island. These guidelines offer health care practitioners detailed advice on the evaluation and management of blood or body fluid exposures outside the health care setting, e.g., through sexual assault, consensual sex, injecting-drug use, or needlestick injuries. In these circumstances, HIV postexposure prophylaxis serves those for whom primary prevention measures have failed or were impractical or impossible. The guidelines represent the end product of coordination among private and public, academic and nonacademic, clinician and layperson groups committed to decreasing the incidence of HIV infections in the state of Rhode Island. The guidelines serve as both a resource for health care practitioners and a means of educating them on this method of HIV prevention.
Full Text
The Full Text of this article is available as a PDF (57.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blauvelt A. The role of skin dendritic cells in the initiation of human immunodeficiency virus infection. Am J Med. 1997 May 19;102(5B):16–20. doi: 10.1016/s0002-9343(97)00055-7. [DOI] [PubMed] [Google Scholar]
- Cardo D. M., Culver D. H., Ciesielski C. A., Srivastava P. U., Marcus R., Abiteboul D., Heptonstall J., Ippolito G., Lot F., McKibben P. S. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med. 1997 Nov 20;337(21):1485–1490. doi: 10.1056/NEJM199711203372101. [DOI] [PubMed] [Google Scholar]
- Connor E. M., Sperling R. S., Gelber R., Kiselev P., Scott G., O'Sullivan M. J., VanDyke R., Bey M., Shearer W., Jacobson R. L. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994 Nov 3;331(18):1173–1180. doi: 10.1056/NEJM199411033311801. [DOI] [PubMed] [Google Scholar]
- Rey D., Bendiane M. K., Moatti J. P., Wellings K., Danziger R., MacDowall W., European Study Group on HIV Testing Policies and Practices in Europe Post-exposure prophylaxis after occupational and non-occupational exposures to HIV: an overview of the policies implemented in 27 European countries. AIDS Care. 2000 Dec;12(6):695–701. doi: 10.1080/09540120020014228. [DOI] [PubMed] [Google Scholar]
- Shaffer N., Chuachoowong R., Mock P. A., Bhadrakom C., Siriwasin W., Young N. L., Chotpitayasunondh T., Chearskul S., Roongpisuthipong A., Chinayon P. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet. 1999 Mar 6;353(9155):773–780. doi: 10.1016/s0140-6736(98)10411-7. [DOI] [PubMed] [Google Scholar]
- Tsai C. C., Emau P., Sun J. C., Beck T. W., Tran C. A., Follis K. E., Bischofberger N., Morton W. R. Post-exposure chemoprophylaxis (PECP) against SIV infection of macaques as a model for protection from HIV infection. J Med Primatol. 2000 Aug;29(3-4):248–258. doi: 10.1034/j.1600-0684.2000.290318.x. [DOI] [PubMed] [Google Scholar]